Kiora Pharmaceuticals annual operating margin
2018
2020
2024
Kiora Pharmaceuticals's operating margin was 28.15% for fiscal 2024.
View full Kiora Pharmaceuticals company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 28.15% | +56988.66 pp |
| 2020 | 2020-12-31 | −56,960.51% | −56304.26 pp |
| 2018 | 2018-12-31 | −656.25% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2024 | 2024-06-30 | −12,724.44% | −11713.98 pp |
| Q1 2024 | 2024-03-31 | 82.64% | +1238.91 pp |
| Q4 2020 | 2020-12-31 | −9,698.80% | −9481.73 pp |
| Q1 2019 | 2019-03-31 | 30.85% | +5573.46 pp |
| Q3 2018 | 2018-09-30 | −1,010.45% | +1232.98 pp |
| Q2 2018 | 2018-06-30 | −1,156.27% | +425.90 pp |
| Q1 2018 | 2018-03-31 | −217.06% | +1014.10 pp |
| Q3 2017 | 2017-09-30 | −5,542.60% | −3911.71 pp |
| Q2 2017 | 2017-06-30 | −2,243.44% | — |
| Q1 2017 | 2017-03-31 | −1,582.17% | — |
| Q3 2016 | 2016-09-30 | −1,231.17% | — |
| Q2 2016 | 2016-06-30 | −1,630.90% | — |
Across the available reported history, Kiora Pharmaceuticals's operating margin increased from −56,960.51% to 28.15%, a change of +56988.66 percentage points. The latest reported quarter, Q2 2024, shows −12,724.44%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kiora Pharmaceuticals filings at SEC.gov ↗